Back
ESC Premium Access

Potential for drug-drug interaction between vonoprazan and prasugrel on antiplatelet effect assessed by VerifyNow P2Y12 assay in patients with coronary artery disease

Session: Poster Session 7 - Acute Coronary Syndromes - Treatment antiplatelet
Topic: Pharmacotherapy
Speaker: Doctor S. Koga (Tokyo, JP)
Event: ESC Congress 2019

Congress Presentation

About the speaker

Doctor Seiji Koga

Juntendo University Nerima Hospital, Tokyo (Japan)
0 follower

9 more presentations in this session

Ischemic and bleeding events during dual antiplatelet therapy after second-generation drug-eluting stent implantation in hemodialysis patients: a propensity score-matched analysis

Speaker: Doctor A. Shimizu (Kitakyushu, JP)

Access
Abstract
Thumbnail

Predictors of bleeding in elderly patients with myocardial infarction: data from the real world

Speaker: Doctor S. Alegria (Almada, PT)

Access
Abstract
Thumbnail

Myocardial infarction with nonobstructive coronary arteries: does aspirin have a place in the treatment of this entity?

Speaker: Doctor J. Ferreira (Coimbra, PT)

Access
Abstract
Thumbnail

Platelet reactivity in Hepatitis C virus infected patients on dual antiplatelet therapy for acute coronary syndrome

Speaker: Doctor F. Scudiero (Seriate, IT)

Access
Abstract
Slides
Thumbnail

Potential benefit of ticagrelor monotherapy for patients with hypertension undergoing percutaneous coronary intervention: Insights from the Global Leaders trial

Speaker: Doctor R. Modolo (Maple Grove, US)

Access
Abstract
Thumbnail

Access the full session

Poster Session 7 - Acute Coronary Syndromes - Treatment antiplatelet

Speakers: Doctor S. Koga, Doctor A. Shimizu, Doctor S. Alegria, Doctor J. Ferreira, Doctor F. Scudiero...
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb